SPOTLIGHT -
Rick Kelly, RPh, MHA, Cyan Health and Nisha Desai, MPH, Cyan Health
Changing Drug Benefit Design & Transparency to Impact Drug Prices
Rick Kelly and Nisha Desai provide an overview of the “American Patients First” blueprint's four key strategies.
Congressional Pushback on Drug Pricing
Rick Kelly and Nisha Desai review the proposals in the Pharmaceutical Drug Pricing Reduction Act (PDPRA) with the greatest potential impact.
American Patients First: Lowering Out of Pocket Costs
In their latest article summarizing efforts to put each of the “American Patients First” blueprint's four strategies into action, Rick Kelly and Nisha Desai focus on the Lowering Out of Pocket (OOP) Costs strategy.
Incentivizing Lower List Prices
In the third in a series of articles summarizing efforts to put each of the “American Patients First” blueprint's four strategies into action, Rick Kelly and Nisha Desai focus on “Incentivizing Lower List Prices.”
Changing the Balance of Negotiation to Impact Drug Prices
In the second in a series of articles summarizing efforts to put each of the “American Patients First” blueprint's four strategies into action, Rick Kelly and Nisha Desai focus on “Better Negotiation”.
A New Pricing Paradigm: Increasing Competition
In the first in a series of articles addressing each of the American Patients First blueprint 's four strategies, Rick Kelly and Nisha Desai focus on “Increasing Competition”.
